Exploratory Study of MT-8554 in Subjects With Painful Diabetic Peripheral Neuropathy

Clinical trial NCT05123196 · COMPLETED

Trial details

NCT number: NCT05123196
Sponsor: Tanabe Pharma Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Painful Diabetic Peripheral Neuropathy

Start date: 2021-11-16
Primary completion: 2022-11-01
Enrollment: 156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.